Brachytherapy Using Elastin-Like Polypeptides with 131I Inhibit Tumor Growth in Rabbits with VX2 Liver Tumor
- 13 June 2016
- journal article
- research article
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 61 (10) , 2921-2927
Abstract
Background Brachytherapy is a targeted type of radiotherapy utilized in the treatment of cancers. Elastin-like polypeptides are a unique class of genetically engineered peptide polymers that have several attractive properties for brachytherapy. Aims To explore the feasibility and application of brachytherapy for VX2 liver tumor using elastin-like polypeptides with 131I so as to provide reliable experimental evidence for a new promising treatment of liver cancer. Methods Elastin-like polypeptide as carrier was labeled with 131I using the iodogen method. Ten eligible rabbits with VX2 liver tumor were randomly divided into the treatment group (n = 5) and control group (n = 5). The treatment group received brachytherapy using elastin-like polypeptide with 131I, and in the control group, elastin-like polypeptide was injected into the VX2 liver tumor as a control. Periodic biochemical and imaging surveillances were required to assess treatment efficacy. Results The stability of elastin-like polypeptide with 131I in vitro was maintained at over 96.8 % for 96 h. Biochemistry and imaging indicated brachytherapy using elastin-like polypeptide with 131I for liver tumor can improve liver function and inhibit tumor growth (P < 0.05). Conclusions Elastin-like polypeptide can be an ideal carrier of 131I and have high labeling efficiency, radiochemical purity and stability. Brachytherapy using elastin-like polypeptide with 131I for liver tumor is a useful therapy that possesses high antitumor efficacy advantages.Keywords
This publication has 17 references indexed in Scilit:
- Transarterial oily chemoembolization with lidamycin shows potent therapeutic efficacy in VX2 rabbit liver tumorOncoTargets and Therapy, 2015
- Adjuvant therapy for hepatocellular carcinoma: current situation and prospect.2013
- Brachytherapy Using Injectable Seeds That Are Self-Assembled from Genetically Encoded Polypeptides In SituCancer Research, 2012
- 125I seed irradiation induces up-regulation of the genes associated with apoptosis and cell cycle arrest and inhibits growth of gastric cancer xenograftsJournal of Experimental & Clinical Cancer Research, 2012
- Evaluation of current practiceAnti-Cancer Drugs, 2011
- Self-assembling elastin-like peptides growth factor chimeric nanoparticles for the treatment of chronic woundsProceedings of the National Academy of Sciences, 2010
- World Gastroenterology Organisation Guideline. Hepatocellular carcinoma (HCC): a global perspective.2010
- Labeling of Acetaminophen with I-131 and Biodistribution in RatsChemical and Pharmaceutical Bulletin, 2006
- Experimental and theoretical determination of dosimetric characteristics of IsoAid ADVANTAGE™ brachytherapy sourceMedical Physics, 2002
- Drug targeting using thermally responsive polymers and local hyperthermiaJournal of Controlled Release, 2001